Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.
Completed
- Conditions
- Post Stroke Spasticity
- Registration Number
- NCT04649632
- Lead Sponsor
- Ipsen
- Brief Summary
Determining the mean/median time between botulinum toxin-A injection within the treatment of patients with spasticity after stroke in relation to the botulinum toxin dose from a healthcare insurance database in the Netherlands.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 451
Inclusion Criteria
- A patient will be included if he has a diagnosis stroke within the rehabilitation setting and has received at least two injections of botulinum toxin-A: Dysport or Botox
Exclusion Criteria
- A patient will be excluded if he has been only treated with Xeomin
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dosing of botulinum toxin-A in daily practice in relation to time to next injection From baseline up to end of data collection (January 2012 up to December 2016) Mean time to next injection per brand From baseline up to end of data collection (January 2012 up to December 2016) Median time to next injection per brand From baseline up to end of data collection (January 2012 up to December 2016)
- Secondary Outcome Measures
Name Time Method Time interval between 2 injections of the same brand From baseline up to end of data collection (January 2012 up to December 2016) Average cost per year per brand per patient From baseline up to end of data collection (January 2012 up to December 2016) Exploring factors like age, gender, time since diagnosis stroke that influence dosing and time between botulinum toxin-A treatments From baseline up to end of data collection (January 2012 up to December 2016)
Trial Locations
- Locations (1)
Ipsen Facility
🇳🇱Hoofddorp, Netherlands